Angela Grech

Assessment of Minimal Residual Disease in Standard-Risk AML

Adam Ivey, Robert K. Hills, Michael A. Simpson et al. · New England Journal of Medicine · 2016 · 812 citations · Full text

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · The Lancet Oncology · 2015 · 533 citations

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +8

An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation

Paul Ferguson, Robert K. Hills, Angela Grech et al. · Haematologica · 2016 · 91 citations · Full text

Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia

Paul Milne, Charlotte S. Wilhelm-Benartzi, Michael R. Grunwald et al. · Blood Advances · 2019 · 22 citations · Full text

An immunophenotypic pre‐treatment predictor for poor response to induction chemotherapy in older acute myeloid leukaemia patients: blood frequency of CD34⁺ CD38^low blasts

Naeem Khan, Sylvie Freeman, Paul Virgo et al. · British Journal of Haematology · 2015 · 12 citations · Full text